(R)-4-Amino-3-(4-fluorophenyl)butanoic acid is a chiral non-proteinogenic amino acid derivative. It features a butanoic acid backbone substituted with an amino group and a 4-fluorophenyl ring at the β-position. The compound is characterized by its (R)-configuration at the chiral center, making it a valuable building block for the synthesis of enantiomerically pure pharmaceuticals. This compound is a key chiral intermediate in the synthesis of several important drugs. Its primary and most significant application is in the production of pregabalin, a widely prescribed medication for neuropathic pain, fibromyalgia, and as an adjunct therapy for partial-onset seizures. The (R)-enantiomer is specifically utilized in certain synthetic routes to pregabalin ((S)-3-(aminomethyl)-5-methylhexanoic acid), a GABA analog. The presence of the fluorine atom on the phenyl ring can be strategically used in subsequent synthetic transformations or to modulate the physicochemical properties of the intermediate. As a high-value pharmaceutical intermediate, its synthesis and supply are critical for the manufacturing of the final active pharmaceutical ingredient (API). Handling requires standard precautions for amino acids and fluorinated organic compounds.